https://www.selleckchem.com/pr....oducts/mcc950-sodium
rt-wearable technology with accelerometers in order to improve agreement and explore less resource-intensive methods to assess PA that could be scalable.The extensively employed limited-gene coverage NGS panels lead to clinically inadequate molecular profiling of myeloid neoplasms. The aim of the present investigation was to assess performance and clinical utility of a comprehensive DNA panel for myeloid neoplasms. Sixty-one previously well characterized samples were sequenced using TSO500 library preparation kit on NextSeq55
Like
Comment
Share
